Recent advances in the Okamoto model: The CD38-cyclic ADP-ribose signal system and the regenerating gene protein (Reg)-Reg receptor system in β-cells

Diabetes

Volumn 51, Issue SUPPL. 3, 2002, Pages

  Okamoto, Hiroshi ^a   Takasawa, Shin ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE RIBOSE; CD38 ANTIGEN; CYCLIC ADENOSINE DIPHOSPHATE RIBOSE; GENE PRODUCT; INSULIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; RECEPTOR PROTEIN; REG RECEPTOR; REGENERATING GENE PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; CELL DEATH; CELL REGENERATION; CONFERENCE PAPER; CONTROLLED STUDY; GENETIC TRANSCRIPTION; INSULIN RELEASE; KNOCKOUT MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TISSUE NECROSIS;

EID: 0036897224     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.51.2007.s462     Document Type: Conference Paper

References (87)

1. Okamoto H: Regulation of proinsulin synthesis in pancreatic islets and a new aspect to insulin-dependent diabetes. Mol Cell Biochem 37:43-61, 1981
2. Okamoto H: Molecular basis of experimental diabetes: Degeneration, oncogenesis, and regeneration of pancreatic B-cells of islets of Langerhans. BioEssays 2:15-21, 1985
3. Okamoto H, Yamamoto H, Takasawa S, Inoue C, Terazono K, Shiga K, Kitagawa M: Molecular mechanism of degeneration, oncogenesis and regeneration of pancreatic B-cells of islets of Langerhans. In Lessons from Animal Diabetes II. Shafrir E, Renold AE, Eds. London, John Libbey, 1988, p. 149-157
4. Okamoto H: The molecular basis of experimental diabetes. In Molecular Biology of the Islets of Langerhans. Okamoto H, Ed. Cambridge, Cambridge University Press, 1990, p. 209-231
5. Okamoto H, Takasawa S, Nata K: The CD38-cyclic ADP-ribose signalling system in insulin secretion: Molecular basis and clinical implications. Diabetologia 40:1485-1491, 1997
6. Okamoto H, Takasawa S, Nata K, Kato I, Tohgo A, Noguchi N: Physiological and pathological significance of the CD38-cyclic ADP-ribose signaling system. Chem Immunol 75:121-145, 2000
7. Takasawa S, Okamoto H: Pancreatic β-cell death, regeneration and insulin secretion: Roles of poly(ADP-ribose) polymerase and cyclic ADP-ribose. Int J Exp Diabetes Res 3:79-96, 2002
8. Takasawa S, Okamoto H: The CD38-cyclic ADP-ribose signal system in pancreatic β-cells: The discovery and biological significance of a novel signal system in mammalian cells. In Cyclic ADP-Ribose and NAADP: Structure, Metabolism and Functions. Lee HC, Ed. Dordrecht, the Netherlands, Kluwer. In press
9. + depletion in type I diabetes. Nature Med 5:269-270, 1999
10. Burkart V, Wang ZQ, Radons J, Heller B, Herceg Z, Stingl L, Wagner EF, Kolb H: Mice lacking the poly(ADP-ribose) polymerase gene are resistant to pancreatic beta-cell destruction and diabetes development induced by streptozocin. Nature Med 5:314-319, 1999
11. Masutani M, Suzuki H, Kamada N, Watanabe M, Ueda O, Nozaki T, Jishage K, Watanabe T, Sugimoto T, Nakagama H, Ochiya T, Sugimura T: Poly(ADP-ribose) polymerase gene disruption conferred mice resistant to streptozotocin-induced diabetes. Proc Natl Acad Sci U S A 96:2301-2304, 1999
12. Pieper AA, Brat DJ, Krug DK, Watkins CC, Gupta A, Blackshaw S, Verma A, Wang ZQ, Snyder SH: Poly(ADP-ribose) polymerase-deficient mice are protected from streptozotocin-induced diabetes. Proc Natl Acad Sci U S A 96:3059-3064, 1999
13. Yamamoto H, Uchigata Y, Okamoto H: Streptozotocin and alloxan induce DNA strand breaks and poly(ADP-ribose) synthetase in pancreatic islets. Nature 294:284-286, 1981
14. Yamammoto H, Uchigata Y, Okammoto H: DNA strand breaks in pancreatic islets by in vivo administration of alloxan or streptozotocin. Biochem Biophys Res Commun 103:1014-1020, 1981
15. Uchigata Y, Yamamoto H, Kawamura A, Okamoto H: Protection by superoxide dismutase, catalase, and poly(ADP-ribose) synthetase inhibitors against alloxan- and streptozotocin-induced islet DNA strand breaks and against the inhibition of proinsulin synthesis. J Biol Chem 257:6084-6088, 1982
16. Uchigata Y, Yamamoto H, Nagai H, Okamoto H: Effect of poly(ADP-ribose) synthetase inhibitor administration to rats before and after injection of alloxan and streptozotocin on islet proinsulin synthesis. Diabetes 32:316-318, 1983
17. Takamura T, Kato I, Kimura N, Nakazawa T, Yonekura H, Takasawa S, Okamoto H: Transgenic mice overexpressing type 2 nitric oxide synthase in pancreatic β cells develop insulin-dependent diabetes without insulitis. J Biol Chem 273:2493-2496, 1998
18. Hoorens A, Pipeleers D: Nicotinamide protects human beta cells against chemically-induced necrosis, but not against cytokine-induced apoptosis. Diabetologia 42:55-59, 1999
19. Eizirik DL, Darville MI: β-cell apoptosis and defense mechanisms: Lessons from type 1 diabetes. Diabetes 50:S64-S69, 2001
20. Germain M, Scovassi I, Poirier GG: Role of poly(ADP-ribose) polymerase in apoptosis. In Cell Death - The Role of Poly(ADP-ribose) Polymerase. Szabó C, Ed. Boca Raton, FL, CRC Press, 2000, p. 209-225
21. Sauter B, Albert ML, Francisco L, Larsson M, Somersan S, Bhardwaj N: Consequences of cell death: Exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J Exp Med 191:423-433, 2000
22. Cocco RE, Ucker DS: Distinct modes of macrophage recognition for apoptotic and necrotic cells are not specified exclusively by phosphatidylserine exposure. Mol Biol Cell 12:919-930, 2001
23. Ueda K, Hayaishi O: ADP-ribosylation. Annu Rev Biochem 54:73-100, 1985
24. Ashcroft FM, Harrison DE, Ashcroft SJH: Glucose induced closure of single potassium channels in isolated rat pancreatic β-cells. Nature 312:446-448, 1984
25. Clapper DL, Walseth TF, Dargie PJ, Lee HC: Pyridine nucleotide metabolites stimulate calcium release from sea urchin egg microsomes desensitized to inositol trisphosphate. J Biol Chem 262:9561-9568, 1987
26. Takasawa S, Nata K, Yonekura H, Okamoto H: Cyclic ADP-ribose in insulin secretion from pancreatic β-cells. Science 259:370-373, 1993
27. 2+ mobilization in normal and diabetic β-cells. J Biol Chem 273:2497-2500, 1998
28. Malaisse WJ, Kanda Y, Inageda K, Scruel O, Sener A, Katada T: Cyclic ADP-ribose measurements in rat pancreatic islets. Biochem Biophys Res Commun 231:546-548, 1997
29. Scruel O, Wada T, Kontani K, Sener A, Katada T, Malaisse WJ: Effects of D-glucose and starvation upon the cyclic ADP-ribose content of rat pancreatic islets. Biochem Mol Biol Int 45:783-790, 1998
30. An NH, Han MK, Um C, Park BH, Park BJ, Kim HK, Kim UH: Significance of ecto-cyclase activity of CD38 in insulin secretion of mouse pancreatic islet cells. Biochem Biophys Res Commun 282:781-786, 2001
31. Takasawa S, Tohgo A, Noguchi N, Koguma T, Nata K, Sugimoto T, Yonekura H, Okamoto H: Synthesis and hydrolysis of cyclic ADP-ribose by human leukocyte antigen CD38 and inhibition of the hydrolysis by ATP. J Biol Chem 268:26052-26054, 1993
32. Koguma T, Takasawa S, Tohgo A, Karasawa T, Furuya Y, Yonekura H, Okamoto H: Cloning and characterization of cDNA encoding rat ADPribosyl cyclase/cyclic ADP-ribose hydrolase (homologue to human CD38) from islets of Langerhans. Biochim Biophys Acta 1223:160-162, 1994
33. Howard M, Grimaldi JC, Bazan JF, Bazan JF, Lund FE, Santos-Argumedo L, Parkhouse RM, Walseth TF, Lee HC: Formation and hydrolysis of cyclic ADP-ribose catalyzed by lymphocyte antigen CD38. Science 262:1056-1059, 1993
34. Tohgo A, Munakata H, Takasawa S, Nata K, Akiyama T, Hayashi N, Okamoto H: Lysine 129 of CD38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase) participates in the binding of ATP to inhibit the cyclic ADPribose hydrolase. J Biol Chem 272:3879-3882, 1997
35. 2+ store in neuroendocrine cells with a vesicle-associated membrane protein aequorin chimaera. J Cell Biol 155:41-51, 2001
36. 2+ from islet microsomes. J Biol Chem 272:3133-3136, 1997
37. Tang W-X, Chen Y-F, Zou A-P, Campbell WB, Li P-L: Role of FKBP12.6 in cADPR-induced activation of reconstituted ryanodine receptors from arterial smooth muscle. Am J Physiol Heart Circ Physiol 282:H1304-H1310, 2002
38. Pirsch JD, Miller J, Deierhoi MH, Vincenti F, Filo RS: A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation: FK506 Kidney Transplant Study Group. Transplantation 63:977-983, 1997
39. 2+ mobilization. J Biol Chem 270:30257-30259, 1995
40. Kato I, Takasawa S, Akabane A, Tanaka O, Abe H, Takamura T, Suzuki Y, Nata K, Yonekura H, Yoshimoto T, Okamoto H: Regulatory role of CD38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase) in insulin secretion by glucose in pancreatic β cells: Enhanced insulin secretion in CD38 transgenic mice. J Biol Chem 270:30045-30050, 1995
41. i and insulin secretion. J Biol Chem 274:1869-1872, 1999
42. Yagui K, Shimada F, Miura M, Hashimoto N, Suzuki Y, Tokuyama Y, Nata K, Tohgo A, Ikehata F, Takasawa S, Okamoto H, Makino H, Saito Y, Kanatsuka A: A missense mutation in the CD38 gene, a novel factor for insulin secretion: Association with type II diabetes mellitus in Japanese subjects and evidence of abnormal function when expressed in vitro. Diabetologia 41:1024-1028, 1998
43. Ikehata F, Satoh J, Nata K, Tohgo A, Nakazawa T, Kato I, Kobayashi S, Akiyama T, Takasawa S, Toyota T, Okamoto H: Autoantibodies against CD38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase) which impair glucose-induced insulin secretion in non-insulin dependent diabetes patients. J Clin Invest 102:395-401, 1998
44. Pupilli C, Giannini S, Marchetti P, Lupi R, Antonelli A, Malavasi F, Takasawa S, Okamoto H, Ferrannini E: Autoanitibodies to CD38 (ADPribosyl cyclase/cyclic ADP-ribose hydrolase) in Caucasian patients with diabetes: Effects on insulin release from human islets. Diabetes 48:2309-2315, 1999
45. Mallone R, Ortolan E, Baj G, Funaro A, Giunti S, Lillaz E, Saccucci F, Cassader M, Cavallo-Perin P, Malavasi F: Autoantibody response to CD38 in Caucasian patients with type 1 and type 2 diabetes: Inmmnological and genetic characterization. Diabetes 50:752-762, 2001
46. Antonelli A, Baj G, Marchetti P, Fallahi P, Surico N, Pupilli C, Malavasi F, Ferrannini E: Human anti-CD38 autoantibodies raise intracellular calcium and stimulate insulin release in human pancreatic islets. Diabetes 50: 985-991, 2001
47. Berridge MJ, Irvine RF: Inositol trisphosphate, a novel second messenger in cellular signal transduction. Nature 312:315-321, 1984
48. Islam MS, Larsson O, Berggren PO, Takasawa S, Nata K, Yonekura H, Okamoto H, Galione A: Cyclic ADP-ribose in β cells. Science 262:584-586, 1993
49. 2+ stores in insulin-secreting cells: Lack of effect of cADP ribose. Cell Calcium 16:71-80, 1994
50. 2+ concentration in the pancreatic β-cell are independent of cyclic ADP-ribose. J Biol Chem 271:19074-19079, 1996
51. Islam MS, Berggren PO: Cyclic ADP-ribose and the pancreatic beta cell: Where do we stand? Diabetologia 40:1480-1484, 1997
52. Matsuoka T, Kajimoto Y, Watada H, Umayahara Y, Kubota M, Kawamori R, Yamasaki Y, Kamada T: Expression of CD38 gene, but not of mitochondrial glycerol-3-phosphate dehydrogenase gene, is impaired in pancreatic islets of GK rats. Biochem Biophys Res Commun 214:239-246, 1995
53. 2+-ATPase (SERCA)-2 and ryanodine receptors. Diabetes 51:S190-S201, 2002
54. 2+ signaling using CD38 knockout mice. J Biol Chem 276:649-655, 2001
55. Higashida H, Yokoyama S, Hashii M, Taketo M, Higashida M, Takayasu T, Ohshima T, Takasawa S, Okamoto H, Noda M: Muscarinic receptormediated dual regulation of ADP-ribosyl cyclase in NG108-15 neuronal cell membranes analyzed by thin layer chromatography. J Biol Chem 272:31272-31277, 1997
56. Isoyama S, Kagaya Y, Narmuchi T, Takeda M, Ninomiya M, Nakamura A, Kato I, Takasawa S, Okamoto H: Development of myocardial hypertrophy in CD38 knockout mice. Circulation 98: 1-626, 1998
57. Xin H-B, Senbonmatsu T, Cheng D-S, Wang Y-X, Copello JA, Ji G-J, Collier ML, Deng Y-X, Jeyakumar LH, Magnuson MA, Inagami T, Kotlikoff MI, Fleischer S: Oestrogen protects FKBP12.6 null mice from cardiac hypertrophy. Nature 416:334-337, 2002
58. 2+ leak through ryanodine receptor in heart failure. Circulation 102:2131-2136, 2000
59. Yonemura Y, Takashima T, Miwa K, Miyazaki I, Yamamoto H, Okamoto H: Amelioration of diabetes mellitus in partially depancreatized rats by poly(ADP-ribose) synthetase inhibitors: Evidence of islet B-cell regeneration. Diabetes 33:401-404, 1984
60. Terazono K, Yamamoto H, Takasawa S, Shiga K, Yonemura Y, Tochino Y, Okamoto H: A novel gene activated in regenerating islets. J Biol Chem 263:2111-2114, 1988
61. Watanabe T, Yonekura H, Terazono K, Yamamoto H, Okamoto H: Complete nucleotide sequence of human reg gene and its expression in normal and tumoral tissues: The reg protein, pancreatic stone protein, and pancreatic thread protein are one and the same product of the gene. J Biol Chem 265:7432-7439, 1990
62. Watanabe T, Yonemura Y, Yonekura H, Suzuki Y, Miyashita H, Sugiyama K, Moriizumi S, Unno M, Tanaka O, Kondo H, Bone AJ, Takasawa S, Okamoto H: Pancreatic beta-cell replication and amelioration of surgical diabetes by Reg protein. Proc Natl Acad Sci U S A 91:3589-3592, 1994
63. Gross DJ, Weiss L, Reibstein I, van den Brand J, Okamoto H, Clark A, Slavin S: Amelioration of diabetes in nonobese diabetic mice with advanced disease by Linomide-induced immunoregulation combined with Reg protein treatment. Endocrinology 139:2369-2374, 1998
64. Unno M, Nata K, Noguchi N, Narushima Y, Akiyama T, Ikeda T, Nakagawa K, Takasawa S, Okamoto H: Production and characterization of Reg knockout mice: Reduced proliferation of pancreatic β-cells in Reg knock-out mice. Diabetes 51 (Suppl. 3): S478-S483, 2002
65. Kobayashi S, Akiyama T, Nata K, Abe M, Tajima M, Shervani NJ, Urmo M, Matsuno S, Sasaki H, Takasawa S, Okamoto H: Identification of a receptor for Reg (regenerating gene) protein, a pancreatic β-cell regeneration factor. J Biol Chem 275:10723-10726, 2000
66. Unno M, Yonekura H, Nakagawara K, Watanabe T, Miyashita H, Moriizumi S, Okamoto H, Itoh T, Teraoka H: Structure, chromosomal localization, and expression of mouse reg genes, reg I and reg II: A novel type of reg gene, reg II, exists in the mouse genome. J Biol Chem 268:15974-15982, 1993
67. Okamoto H: The Reg gene family and Reg proteins: With special attention to the regeneration of pancreatic β-cells. J Hepatobiliary Pancreat Surg 6:254-262, 1999
68. Akiyama T, Takasawa S, Nata K, Kobayashi S, Abe M, Shervani NJ, Ikeda T, Nakagawa K, Unno M, Matsuno S, Okamoto H: Activation of Reg gene, a gene for insulin-producing β-cell regeneration: Poly(ADP-ribose) polymerase binds Reg promoter and regulates the transcription by autopoly-(ADP-ribosyl)ation. Proc Natl Acad Sci U S A 98:48-53, 2001
69. Nirodi C, NagDas S, Gygi SP, Olson G, Aebersold R, Richmond A: A role for poly(ADP-ribose) polymerase in the transcriptional regulation of the melanoma growth stimulatory activity (CXCL1) gene expression. J Biol Chem 276:9366-9374, 2001
70. Chang WJ, Alvarez-Gonzalez R: The sequence-specific DNA binding of NF-kappa B is reversibly regulated by automodification reaction of poly-(ADP-ribose) polymerase 1. J Biol Chem 276:47664-47670, 2001
71. Soldatenkov VA, Chasovskikh S, Potaman VN, Trofimova I, Smulson ME, Dritschilo A: Transcriptional repression by binding of poly(ADP-ribose) polymerase to promoter sequences. J Biol Chem 277:665-670, 2002
72. Moriizumi S, Watanabe T, Unno M, Nakagawara K, Suzuki Y, Miyashita H, Yonekura H, Okamoto H: Isolation, structural determination and expression of a novel reg gene, human reg 1β. Biochim Biophys Acta 1217:199-202, 1994
73. Miyashita H, Nakagawara K, Mori M, Narushima Y, Noguchi N, Moriizumi S, Takasawa S, Yonekura H, Takeuchi T, Okamoto H: Human REG family genes are tandemly ordered in a 95-kilobase region of chromosome 2p12. FEBS Lett 377:429-433, 1995
74. Hartupee JC, Zhang H, Bonaldo MF, Soares MB, Dieckgraefe BK: Isolation and characterization of a cDNA encoding a novel member of the human regenerating protein family: Reg IV. Biochim Biophys Acta 1518:287-293, 2001
75. Abe M, Nata K, Akiyama T, Shervani NJ, Kobayashi S, Tomioka-Kumagai T, Ito S, Takasawa S, Okamoto H: Identification of a novel Reg family gene, Reg IIIδ, and mapping of all three types of Reg family genes in a 75 kilobase mouse genomic region. Gene 246:111-122, 2000
76. Livesey JF, O'Brien AJ, Li M, Smith GA, Murphy JL, Hunt PS: A Schwann cell mitogen accompanying regeneration of motor neurons. Nature 390: 614-618, 1997
77. Nishimune H, Vasseur S, Wiese S, Birling MC, Holtmann B, Sendtner M, Iovarma JL, Henderson CE: Reg-2 is a motoneuron neurotrophic factor and a signalling intermediate in the CNTF survival pathway. Nature Cell Biol 2:906-914, 2000
78. Fukui H, Kinoshita Y, Maekawa T, Okada A, Waki S, Hassan S, Okamoto H, Chiba T: Regenerating gene protein may mediate gastric mucosal proliferation induced by hypergastrinemia in rats. Gastroenterology 115:1483-1493, 1998
79. Kazumori H, Ishirara S, Hoshino E, Kawashima K, Moriyama N, Suetsugu H, Sato H, Adachi K, Fukuda R, Watanabe M, Takasawa S, Okamoto H, Fukui H, Chiba T, Kinoshita Y: Neutrophil chemoattractant-2β regulates the expression of the Reg gene in injured gastric mucosa in rats. Gastroenterology 119:1610-1622, 2000
80. Schatz DA, Bingley PJ: Update on major trials for the prevention of type 1 diabetes mellitus: The American Diabetes Prevention Trial (DPT-1) and the European Nicotinamide Diabetes Intervention Trial (ENDIT). J Pediatr Endocrino Metab 14:619-622, 2001
81. Lampeter EF, Klinghammer A, Scherbaum WA, Heinze E, Haastert B, Giani G, Kolb H, the DENIS Group: The Deutsche Nicotinamide Intervention Study: An attempt to prevent type 1 diabetes. Diabetes 47:980-984, 1998
82. Pozzili P, Visalli N, Cavallo MG, Signore A, Baroni MG, Buzzetti R, Fioriti E, Mesturino C, Fiori R, Romiti A, Giovannini C, Lucentini L, Matteoli MC, Crinò A, Teodonio C, Paci F, Amoretti R, Pisano L, Suraci MT, Multari G, Suppa M, Sulli N, De Mattia G, Faldetta MRC, Boscherini B, Stoduto S, Fonte MT, Bitti MLM, Marietti G, Ferrazzoli F, Greco AV, Ghirlanda G: Vitamin E and nicotinamide have similar effects in maintaining residual beta cell function in recent onset insulin-dependent diabetes (the IMDIAB IV study). Eur J Endocrinol 137:234-239, 1997
83. Elliott RB, Pilcher CC, Fergusson DM, Stewart AW: A population based strategy to prevent insulin-dependent diabetes using nicotinamide. J Pediatr Endocrionol Metab 9:501-509, 1996
84. Gale EA: Theory and practice of nicotinamide trials in pre-type 1 diabetes. J Pediatr Endocrinol Metab 9:375-379, 1996
85. Knip M, Douek IF, Moore WPT, Gillmor HA, McLean AEM, Bingley PJ, Gale EAM: Safety of high-dose nicotinamide: A review. Diabetologia 43:1337-1345, 2000
86. Soriano FG, Virág L, Jagtap P, Szabó E, Mabley JG, Liaudet L, Marton A, Hoyt DG, Murthy KGK, Salzman AL, Southan GJ, Szabó C: Diabetic endothelial dysfunction: The role of poly(ADP-ribose) polymerase activation. Nature Med 7:108-113, 2001
87. Pacher P, Liaudet L, Soriano FG, Mabley JG, Szabó E, Szabó C: The role of poly(ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes. Diabetes 51:514-521, 2002